The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.
By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an ...
By Sneha S K and Sriparna Roy (Reuters) - The U.S. Food and Drug Administration said on Friday that it has approved an ...
Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...